Wave Life Sciences (WVE) Net Cash Flow (2014 - 2026)
Wave Life Sciences (WVE) posted Net Cash Flow of -$57.5 million for Q1 2026, down 114.16% on a QoQ basis from $405.9 million in Q4 2025, and up 2.68% year-over-year from -$56.0 million in Q1 2025.
Wave Life Sciences (WVE) Net Cash Flow (2014 - 2026) Analysis & Trends
Wave Life Sciences' Net Cash Flow history runs 13 years deep, the most recent figure standing at -$57.5 million for Q1 2026.
- Quarterly Net Cash Flow rose 2.68% year-over-year to -$57.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $301.6 million (up 384.78% YoY) and the FY2025 annual result came in at $300.0 million, up 194.35% from the prior year.
- Net Cash Flow was -$57.5 million for Q1 2026 at Wave Life Sciences, down from $405.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $405.9 million in Q4 2025 and bottomed at -$88.8 million in Q1 2022.
- A 5-year average of $23.2 million and a median of -$19.3 million in 2024 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 4737.5% in 2025, while the deepest fall reached 205.34% in 2025.
- Wave Life Sciences' Net Cash Flow stood at -$8.5 million in 2022, then surged by 806.46% to $60.4 million in 2023, then slumped by 114.5% to -$8.8 million in 2024, then soared by 4737.5% to $405.9 million in 2025, then slumped by 114.16% to -$57.5 million in 2026.
- Business Quant data shows WVE's Net Cash Flow at -$57.5 million in Q1 2026, $405.9 million in Q4 2025, and -$12.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -57.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.46 Mn |
| Mar 31, 2026 | -57.46 Mn |
| Dec 31, 2025 | 405.92 Mn |
| Dec 31, 2025 | 405.92 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Sep 30, 2025 | -12.22 Mn |
| Jun 30, 2025 | -34.63 Mn |
| Jun 30, 2025 | -34.63 Mn |
| Mar 31, 2025 | -59.05 Mn |
| Mar 31, 2025 | -59.05 Mn |
| Dec 31, 2024 | -8.75 Mn |
| Dec 31, 2024 | -8.75 Mn |
| Sep 30, 2024 | 156.89 Mn |
| Sep 30, 2024 | 156.89 Mn |
| Jun 30, 2024 | -26.87 Mn |
| Jun 30, 2024 | -26.87 Mn |
| Mar 31, 2024 | -19.34 Mn |
| Mar 31, 2024 | -19.34 Mn |
| Dec 31, 2023 | 60.37 Mn |
| Dec 31, 2023 | 60.37 Mn |